What is Genecis?
Genecis Bioindustries operates at the intersection of synthetic biology and industrial manufacturing. The company utilizes advanced fermentation processes to transform organic waste streams into polyhydroxyalkanoates (PHA), a class of biodegradable materials that serve as direct, eco-friendly alternatives to conventional single-use plastics. Their market position is defined by a dual-value proposition: providing waste management solutions for organic producers while delivering high-quality, sustainable material inputs for sectors ranging from medical devices to consumer textiles. By offering comprehensive services in polymer development and rapid product prototyping, Genecis enables corporate partners to meet aggressive ESG targets without sacrificing material performance or operational profitability.
How much funding has Genecis raised?
Genecis has raised a total of $10M across 2 funding rounds:
Debt
$3M
Series A
$7M
Debt (2022): $3M with participation from Silicon Valley Bank
Series A (2022): $7M led by Khosla Ventures Acquisition, BDC Capital Management, AME Cloud Ventures, and Gullspång Re:food
Key Investors in Genecis
Khosla Ventures Acquisition
A prominent venture capital firm known for backing high-impact technology companies and providing the strategic guidance necessary for scaling complex industrial innovations.
AME Cloud Ventures
A venture fund led by Jerry Yang that focuses on infrastructure and data-heavy companies, providing operational expertise and access to global networks.
Gullspång Re:food
A transatlantic growth equity investor specializing in agrifood and sustainable systems, dedicated to supporting companies that address global food and environmental challenges.
What's next for Genecis?
With this major strategic investment, Genecis is poised to enter a phase of rapid industrial scaling. The company's roadmap likely involves expanding its manufacturing footprint to meet the surging demand for sustainable packaging alternatives in the European and North American markets. Furthermore, the firm is expected to deepen its R&D efforts to optimize the cost-efficiency of its PHA production, potentially unlocking new applications in the automotive and medical sectors. As the regulatory landscape continues to tighten around single-use plastics, Genecis is strategically positioned to capture significant market share, leveraging its circular economy model to become a foundational supplier for the next generation of sustainable consumer goods.
See full Genecis company page
